Dr. Kishan calls for more prospective studies on the predictive nature of germline variants

Video

“What really needs to be done to show that this works is to look prospectively,” says Amar U. Kishan, MD.

In this video, Amar U. Kishan, MD, discusses the takeaways of the study, “Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.” Kishan is an associate professor in the department of radiation oncology, chief of genitourinary oncology service, and vice chair of clinical and translational research at the University of California, Los Angeles.

Related Videos
Mara R. Holton, MD, answers a question during a Zoom video interview
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
Illustration of kidney stones | Image Credit: © freshidea - stock.adobe.com
United States Capitol Building | Image Credit: © rrodrickbeiler - stock.adobe.com
Roger R. Dmochowski, MD, MMHC, FACS, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.